BRBS
Blue Ridge Bankshares, Inc.
There isn't enough reported data to score BRBS yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BRBS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
BRBS's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like BRBS.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BRBS PE Valuation
BRBS has no meaningful PE right now: it lost money over the past year.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BRBS Forward outlook
There aren't enough analyst estimates for BRBS to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BRBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.92 | +$1.74 |
| Q2 2024 | -$3.11 | -$2.78 |
| Q1 2024 | -$3.09 | -1817% |
| Q4 2023 | -$2.73 | -397% |
| Q3 2023 | -$2.66 | -232% |
| Q2 2023 | -$0.33 | -115% |
| Q1 2023 | $0.18 | -95% |
BRBS has the stronger earnings trend. Trailing diluted EPS is down 100% for BRBS versus IREN down 347%.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BRBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20M | -22% |
| Q2 2026 | $18.3M | -21% |
| Q1 2026 | $19.3M | -13% |
| Q4 2025 | $20.8M | -4.7% |
| Q3 2025 | $25.7M | +18% |
| Q2 2025 | $23.1M | +13% |
| Q1 2025 | $22.1M | -22% |
| Q4 2024 | $21.8M | -16% |
BRBS's revenue has slid since its 2021 peak: $20M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -51 points |
| Q2 2026 | -8.9% | -17 points |
| Q1 2026 | 5.8% | +9.8 points |
| Q4 2025 | 26% | +38 points |
| Q3 2025 | 29% | +22 points |
| Q2 2025 | 7.7% | +67 points |
| Q1 2025 | -4% | +7.7 points |
| Q4 2024 | -12% | +17 points |
BRBS has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over BRBS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was โ82% last quarter, down 50 points from the same quarter a year ago.
BRBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.5M | -21% |
| Q2 2026 | $1.5M | -86% |
| Q1 2026 | $14.6M | +$18.2M |
| Q4 2025 | -$699K | +$17.5M |
| Q3 2025 | $5.7M | -76% |
| Q2 2025 | $10.5M | +$15.5M |
| Q1 2025 | -$3.6M | +$4M |
| Q4 2024 | -$18.2M | -190% |
BRBS has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was โ$2.5B over the past year, against โ$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BRBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 89.6x | High |
| Q2 2026 | 7.5x | High |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 6.2x | High |
| Q2 2025 | 37.9x | High |
| Q1 2023 | 7.9x | High |
| Q4 2022 | 11.4x | High |
BRBS's net debt is more than 20 years of its operating earnings (EBITDA), up from 6.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BRBS.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BRBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 67.1 | Neutral |
BRBS's weekly RSI is 58 (neutral) and its Stochastic is 67 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BRBS PE vs Financial Services Sector
| Metric | BRBS | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 13x | 184% above |
| PE % | 92 | 63 | 29 pts above |
BRBS has no meaningful PE right now: it lost money over the past year.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
IREN has no meaningful PE right now: it lost money over the past year.
BRBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.95 | 2% above |
| 20 week MA | $3.81 | 5.8% above |
| 50 week MA | $3.88 | 3.9% above |
| 100 week MA | $3.77 | 6.9% above |
| 200 week MA | $4.53 | 11% below |
BRBS has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BRBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.7 | $11.9 | -13% |
| 2021 | $11.9 | $17.8 | +49% |
| 2022 | $17.8 | $12.4 | -30% |
| 2023 | $12.4 | $3.03 | -76% |
| 2024 | $3.03 | $3.19 | +5.3% |
| 2025 | $3.19 | $4.37 | +37% |
| 2026 YTD | $4.37 | $4.03 | -7.8% |
BRBS has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to โ93% in 2022. It's down 52% so far in 2026.